← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2011Last known activity
Feb 10, 2017
Acquired by Biogen-IDEC on Jan 1, 2015
Timeline
2010s
- Jan 1, 2010
Convergence Pharmaceuticals— Founded
- Jan 1, 2015
Biogen-IDEC— Acquired By
Drugs by trial phase (2 distinct, 9 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT02957617Study directorPhase 2Feb 10, 2017
- NCT02957617Lead sponsorPhase 2Feb 10, 2017
- NCT02935608Study directorPhase 2Oct 31, 2016
- NCT02935608Lead sponsorPhase 2Oct 31, 2016
- NCT02917187Lead sponsorPhase 2Sep 1, 2016
- NCT02917187Study directorPhase 2Sep 1, 2016
- NCT02551497Study directorPhase 1Apr 30, 2015
- NCT02551497Lead sponsorPhase 1Apr 30, 2015
- NCT02359344Lead sponsorPhase 1Feb 1, 2015
- NCT01893125Lead sponsorPhase 2Aug 1, 2013
- NCT01848730Lead sponsorPhase 2Apr 1, 2013
- NCT01540630Lead sponsorPhase 2Mar 1, 2012
- NCT01561027Lead sponsorPhase 2Apr 1, 2011
Details
- Founded
- Cambridge, GB Jan 1, 2010
- Last known activity
- Feb 10, 2017